BIFOLD and Aignostics researchers introduce PathoROB
A new study published in Nature Communications by researchers from BIFOLD and Aignostics shows that today's pathology foundation models can be fooled by the hospital a tissue sample comes from.…
36 trillion cells, 400 cell types, 60 different tissues and organs: The sheer volume and complexity explain why changes are often not detected at the onset of a disease, but only when the first symptoms become apparent.
This is where the Einstein…
Transferring Research Into Practice For Patients With Rheumatic Diseases
European Research Council will fund project on the simulation of biomolecular dynamics with just over three million euros
A new study from the German Institute of Human Nutrition Potsdam–Rehbruecke (DIfE) and Charité – Universitätsmedizin Berlin shows for the first time that targeted control of human breathing rhythm can influence decision behavior by modulating heart…
ckert & Ziegler SE (ISIN DE0005659700, TecDAX) today officially opened the new medical isotope production site of its joint venture Qi Kang Medical Technology (Changzhou) Co., Ltd. (QKM) in the Jintan district of Changzhou, China. With the opening,…
International consortium including Germany, Poland and Ukraine evaluates the safety and efficacy of Invobenitug as a targeted therapy for septic, burn and traumatic shock, aiming to improve patient outcomes and advance critical care across Europe.
Nuvisan ICB GmbH, a fully integrated contract research organisation providing drug discovery and development services (“Nuvisan”), is pleased to announce it has received a US$25 million grant from the Gates Foundation to advance a portfolio of novel…
Pentixapharm Holding AG (Frankfurt Prime Standard: PTP), a clinical-stage biotech developing novel radiopharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for…
With the groundbreaking of the Berlin Center for Gene and Cell Therapies and the opening of the Berlin Center for Advanced Therapies at Charité, Berlin-Brandenburg is stepping up efforts to position itself as a leading location for advanced and…
